VAST RENEWABLES LIMITED (VSTE) Fundamental Analysis & Valuation

NASDAQ:VSTEAU0000288284

Current stock price

0.132 USD
-0.03 (-19.07%)
At close:
0.1383 USD
+0.01 (+4.77%)
After Hours:

This VSTE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. VSTE Profitability Analysis

1.1 Basic Checks

  • In the past year VSTE has reported negative net income.
  • In the past year VSTE has reported a negative cash flow from operations.
  • VSTE had negative earnings in 4 of the past 5 years.
  • In the past 5 years VSTE reported 4 times negative operating cash flow.
VSTE Yearly Net Income VS EBIT VS OCF VS FCFVSTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M -250M

1.2 Ratios

  • VSTE has a Return On Assets of -2395.08%. This is amonst the worse of the industry: VSTE underperforms 96.84% of its industry peers.
Industry RankSector Rank
ROA -2395.08%
ROE N/A
ROIC N/A
ROA(3y)-620.14%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSTE Yearly ROA, ROE, ROICVSTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1K -1K 2K 3K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for VSTE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSTE Yearly Profit, Operating, Gross MarginsVSTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -20K -40K -60K -80K

2

2. VSTE Health Analysis

2.1 Basic Checks

  • VSTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for VSTE has been reduced compared to 1 year ago.
  • Compared to 1 year ago, VSTE has a worse debt to assets ratio.
VSTE Yearly Shares OutstandingVSTE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
VSTE Yearly Total Debt VS Total AssetsVSTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • Based on the Altman-Z score of -69.73, we must say that VSTE is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of VSTE (-69.73) is worse than 96.84% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -69.73
ROIC/WACCN/A
WACC5.8%
VSTE Yearly LT Debt VS Equity VS FCFVSTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • VSTE has a Current Ratio of 1.11. This is a normal value and indicates that VSTE is financially healthy and should not expect problems in meeting its short term obligations.
  • VSTE's Current ratio of 1.11 is on the low side compared to the rest of the industry. VSTE is outperformed by 67.37% of its industry peers.
  • A Quick Ratio of 1.03 indicates that VSTE should not have too much problems paying its short term obligations.
  • VSTE's Quick ratio of 1.03 is in line compared to the rest of the industry. VSTE outperforms 48.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.03
VSTE Yearly Current Assets VS Current LiabilitesVSTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

3. VSTE Growth Analysis

3.1 Past

  • VSTE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31157.18%.
EPS 1Y (TTM)-31157.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.04%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
VSTE Yearly Revenue VS EstimatesVSTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 100K 200K 300K

0

4. VSTE Valuation Analysis

4.1 Price/Earnings Ratio

  • VSTE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSTE Price Earnings VS Forward Price EarningsVSTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSTE Per share dataVSTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. VSTE Dividend Analysis

5.1 Amount

  • VSTE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

VSTE Fundamentals: All Metrics, Ratios and Statistics

VAST RENEWABLES LIMITED

NASDAQ:VSTE (5/23/2025, 9:02:42 PM)

After market: 0.1383 +0.01 (+4.77%)

0.132

-0.03 (-19.07%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.3%
Inst Owner Change-0.61%
Ins Owners4.82%
Ins Owner ChangeN/A
Market Cap3.96M
Revenue(TTM)342.00K
Net Income(TTM)-293.44M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.57
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-11.68
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)-0.54
OCFYN/A
SpS0.01
BVpS-0.13
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2395.08%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-620.14%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 116.92%
Cap/Sales 44.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 1.03
Altman-Z -69.73
F-Score2
WACC5.8%
ROIC/WACCN/A
Cap/Depr(3y)78.72%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31157.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6336.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1347.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1343.47%
OCF growth 3YN/A
OCF growth 5YN/A

VAST RENEWABLES LIMITED / VSTE Fundamental Analysis FAQ

What is the fundamental rating for VSTE stock?

ChartMill assigns a fundamental rating of 1 / 10 to VSTE.


What is the valuation status of VAST RENEWABLES LIMITED (VSTE) stock?

ChartMill assigns a valuation rating of 0 / 10 to VAST RENEWABLES LIMITED (VSTE). This can be considered as Overvalued.


What is the profitability of VSTE stock?

VAST RENEWABLES LIMITED (VSTE) has a profitability rating of 0 / 10.


How financially healthy is VAST RENEWABLES LIMITED?

The financial health rating of VAST RENEWABLES LIMITED (VSTE) is 2 / 10.